News for hackers. Stuff that matters.

A comment on Three authors retract study on hydroxychloroquine and chloroquine. Parent comment

Re:Three authors retract study on hydroxychloroquine and chl... by tunesmith on Thursday June 04, 2020 @05:59PM (#23422449)
What's the economic interest of claiming the medication doesn't work?
[ Parent | on HN ]
Re:Three authors retract study on hydroxychloroquine and chl... by comicjk on Thursday June 04, 2020 @06:09PM (#23422572)
The company that provided the data, Surgisphere, might have been trying to raise their profile by getting a big publication. They're a bit shady.

https://blogs.sciencemag.org/pipeline/archives/2020/06/02/su...

[ Parent | on HN ]
Re:Three authors retract study on hydroxychloroquine and chl... by saas_sam on Thursday June 04, 2020 @06:01PM (#23422473)
To prop up a competing medication.
[ Parent | on HN ]
Re:Three authors retract study on hydroxychloroquine and chl... by rlp on Thursday June 04, 2020 @06:01PM (#23422477)
Increased sales of a competing medication, like Remdesivir.
[ Parent | on HN ]
Re:Three authors retract study on hydroxychloroquine and chl... by pdog on Thursday June 04, 2020 @06:33PM (#23422791)
There a huge battle going on between hydroxychloroquine (the Republican therapy of choice when combined with a zinc supplement) and remdesivir (the antiviral drug by Gilead that's preferred by anti-Trump liberals).

To answer your question, there can be an economic interest in claiming a competitor treatment (which is generic and manufactured cheaply) doesn't work.

[ Parent | on HN ]